These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme. Parvez T Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496 [TBL] [Abstract][Full Text] [Related]
14. Viral therapy for glioblastoma. Chiocca EA; Aghi M; Fulci G Cancer J; 2003; 9(3):167-79. PubMed ID: 12952302 [TBL] [Abstract][Full Text] [Related]
15. DNA repair mechanisms and their clinical impact in glioblastoma. Erasimus H; Gobin M; Niclou S; Van Dyck E Mutat Res Rev Mutat Res; 2016; 769():19-35. PubMed ID: 27543314 [TBL] [Abstract][Full Text] [Related]
16. HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme. Herranz M; Padín-Iruegas ME; Martínez-Lago N; Losada SA; Raña-Díez P; Vázquez EB; Carrera JJ; Antúnez JR; Ruibal A; López-López R Mol Neurobiol; 2016 Apr; 53(3):1802-1807. PubMed ID: 25752997 [TBL] [Abstract][Full Text] [Related]
17. Clonal diversity in glioblastoma: is it clinically relevant? Watts C; Piccirillo SG Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436 [TBL] [Abstract][Full Text] [Related]
18. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy. Parsa AT World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908 [No Abstract] [Full Text] [Related]
19. Molecular biology of glioma. Marumoto T; Saya H Adv Exp Med Biol; 2012; 746():2-11. PubMed ID: 22639155 [TBL] [Abstract][Full Text] [Related]